---
title: "CINGW.US (CINGW.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CINGW.US/news.md"
symbol: "CINGW.US"
name: "CINGW.US"
parent: "https://longbridge.com/en/quote/CINGW.US.md"
datetime: "2026-03-10T00:29:16.627Z"
locales:
  - [en](https://longbridge.com/en/quote/CINGW.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CINGW.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CINGW.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/CINGW.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/CINGW.US/news.md)


# CINGW.US (CINGW.US) — Related News

### [Recent Key Industry Opportunities](https://longbridge.com/en/news/278458445.md)
*2026-03-09T23:05:35.000Z*
> Recently, global geopolitical conflicts and domestic policy dividends have intertwined, and the A-share market has shown

### [14:04 ETGlaucoma Research Foundation Announces Record $3.06 million in Annual Research Grants to Fund their 2026 Shaffer Grants and Catalyst for a Cure Research Collaborations](https://longbridge.com/en/news/278431651.md)
*2026-03-09T18:05:35.000Z*
> The Glaucoma Research Foundation (GRF) has announced a record $3.06 million in annual research grants to support innovat

### [FDA Issues New Draft Guidance For Biosimilar Development](https://longbridge.com/en/news/278425896.md)
*2026-03-09T16:56:27.000Z*
> March 9 (Reuters) - FDA:* FDA TAKES FURTHER STEPS TO STREAMLINE BIOSIMILAR DEVELOPMENT AND MAKE MEDICINES MORE AFFORDABL

### [BUZZ-U.S. STOCKS ON THE MOVE-Biotechs, Agilent, Dow](https://longbridge.com/en/news/278418396.md)
*2026-03-09T15:46:58.000Z*
> On March 6, U.S. stocks fell over 1% as oil prices surged, raising inflation concerns amid ongoing Middle East tensions.

### [<![CDATA[Mergers and Acquisitions Roundup: GSK and Alfasigma Enter Licensing Agreement for Linerixibat, Servier Enters $2.5 Billion Definitive Agreement to Acquire Day One Pharmaceuticals ]]>](https://longbridge.com/en/news/278405078.md)
*2026-03-09T13:35:16.000Z*
> The pharmaceutical sector is witnessing significant consolidation, highlighted by two major deals. GSK has entered a $69

### [CINGULATE INC C/WTS 10/12/2026 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 0](https://longbridge.com/en/news/265800829.md)
*2025-11-13T22:23:37.000Z*
### [CINGULATE INC C/WTS 10/12/2026 (TO PUR COM) | 8-K: FY2025 Q3 Revenue: USD 0](https://longbridge.com/en/news/265738023.md)
*2025-11-13T13:17:13.000Z*
### [CINGULATE INC C/WTS 10/12/2026 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD -1.09](https://longbridge.com/en/news/253649060.md)
*2025-08-19T12:58:20.000Z*
### [CINGULATE INC C/WTS 10/12/2026 (TO PUR COM) | 8-K: FY2025 Q2 EBIT: USD -4.65 M](https://longbridge.com/en/news/253647628.md)
*2025-08-19T12:53:30.000Z*
### [CINGULATE INC C/WTS 10/12/2026 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD -1.04](https://longbridge.com/en/news/239424967.md)
*2025-05-08T20:42:19.000Z*